NCT04251884

Pudendal Nerve Block for Hemorrhoidectomy

Pudendal Nerve Block in Patient Treated for Hemorrhoidectomy Under Spinal Anaesthesia: Prospective Randomized Double-blind Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 49 (actual)
• Sponsor: Francesco Mongelli · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Patients undergoing Milligan-Morgan hemorrhoidectomy will be randomized to receive or not the pudendal nerve block after the spinal anesthesia.

Detailed description

Patients included were those undergoing Milligan-Morgan hemorrhoidectomy under spinal anaesthesia from January 2018 to December 2019. Exclusion criteria were age \< 18 years old, pregnancy and allergy to local anaesthetics. Patients meeting inclusion and exclusion criteria were randomized to undergo an ultrasound-guided pudendal nerve block. Per-protocol all patients received postoperative metronidazole 500 mg for 3 days, laxative, a basis analgesia with NSAID and opioids as needed. Postoperative pain on the visual analogue scale (VAS) at 6, 12, 24 and 48 hours, opioids needed, complications and length of hospital stay were recorded. Patients and ward personnel were not informed about the treatment arm. All Patients were further controlled 6 weeks after the intervention.

Conditions

• Hemorrhoids
• Postoperative Pain

Interventions

Type	Name	Description
PROCEDURE	Local anesthetic (ropivacaine)	Patients randomized in the treatment arm will receive a sonography-guided pudendal nerve block

Timeline

• Start date: 2018-01-01
• Primary completion: 2019-12-29
• Completion: 2020-01-30
• First posted: 2020-02-05
• Last updated: 2022-03-11
• Results posted: 2020-06-05

Locations

1 site across 1 country: Switzerland